India's 'Woman Warren Buffett' Unveils 2 Stocks Trading at Huge Discounts – Opportunity or Trap?

Vanaja Sundar Iyer, a highly respected investor often dubbed India's 'Woman Warren Buffett,' has recently focused investor attention on two companies within her portfolio: Bajaj Healthcare Ltd and TCC Concept Ltd. Both stocks are presently trading at significant discounts from their all-time highs, sparking debate about whether this represents a prime investment opportunity.

Who is Vanaja Sundar Iyer?

Vanaja Sundar Iyer is a prominent figure in the Indian investment community, recognized for her strategic stock picks across diverse sectors including automobiles, industrial manufacturing, and real estate. Beyond her financial expertise, she is also known for her extensive community service and mentoring initiatives.

Bajaj Healthcare: A Turnaround Bet

• Company Overview: Incorporated in 1993, Bajaj Healthcare Ltd manufactures a wide array of Active Pharmaceutical Ingredients (APIs) and Formulations. With a market capitalization of Rs 1,352 crore, the company serves the pharmaceutical, nutraceutical, and food industries, specializing in Amino Acids and Nutritional Supplements.
• Financial Performance: The company's sales experienced growth between FY20 and FY22 but saw a decline in FY23 and FY24, before recovering in FY25. Financial metrics like EBITDA and net profits have shown a similar pattern, with FY24 recording a loss but FY25 and the first half of FY26 indicating a return to profitability.
  • Sales (Cr): FY20: 410, FY21: 657, FY22: 680, FY23: 646, FY24: 473, FY25: 543. First half of FY26: 297.
  • EBITDA (Cr): FY20: 48, FY21: 136, FY22: 119, FY23: 112, FY24: 76, FY25: 82. First half of FY26: 52.
  • Profits (Cr): FY20: 25, FY21: 83, FY22: 71, FY23: 43, FY24: -84, FY25: 40. First half of FY26: 23.
• Stock Performance & Valuation: Bajaj Healthcare's share price has seen an 85% increase since November 2020. Currently trading around Rs 427, it represents a 43% discount from its all-time high of Rs 745. The stock's Price-to-Earnings (PE) ratio stands at 26x, which is lower than the current industry median of 31x and its own 10-year median PE of 19x.
• Management Outlook: Managing Director Anil Jain expressed optimism, highlighting a "strong foundation, enhanced regulatory preparedness, and continued investment in R&D," positioning the company for sustained growth.

TCC Concept: The Multibagger with a Pepperfry Twist

• Company Overview: TCC Concept Ltd, established in 1984, operates in real estate services, property management, and leasing, functioning as a flexible office space aggregator and a real estate brokerage firm. Its market capitalization is Rs 1,771 crore.
• Financial Performance: TCC Concept has demonstrated exceptional growth, with sales soaring from Rs 1 crore in FY23 to Rs 83 crore in FY25, achieving a Compound Annual Growth Rate (CAGR) of 811%. EBITDA and net profits have also seen substantial increases.
  • Sales (Cr): FY23: 1, FY25: 83. First half of FY26: 49.
  • EBITDA (Cr): FY23: 1, FY25: 60. First half of FY26: 39.
  • Profits (Cr): FY23: 1, FY25: 42. First half of FY26: 19.
• Stock Performance & Valuation: The share price has surged approximately 3,000% since its listing in June 2023, reaching Rs 496. However, it is trading at a 38% discount from its all-time high of Rs 798. The current PE ratio is 38x, slightly above the industry median of 35x.
• Pepperfry Acquisition: TCC Concept is set to acquire nearly 99% of Pepperfry Limited, a major omnichannel furniture and home goods e-commerce marketplace in India. This strategic acquisition is structured as a share-swap deal valued at Rs 661.47 crore, with an expected completion by December 15, 2025.

Investor Opportunity: Discounted Stocks

Both companies, having recently attracted Vanaja Iyer's attention, now present a puzzle for investors. Their current valuations are significantly lower than their peaks, despite strong or recovering financial performances and strategic expansions like TCC's Pepperfry acquisition. Investors are advised to consider adding these stocks to their watchlist for further monitoring.

Impact

• This news could potentially increase investor interest in Bajaj Healthcare Ltd and TCC Concept Ltd, possibly leading to upward price movements if market sentiment aligns with the perceived value opportunity. It may also draw attention to other undervalued stocks in the pharmaceutical and real estate/e-commerce sectors.
• Impact Rating: 7/10

Difficult Terms Explained

• Super Investor: An investor who has a proven track record of making significant profits through smart stock selections.
• Active Pharmaceutical Ingredients (APIs): The core chemical components in medicines that produce the intended therapeutic effect.
• Formulations: Finished dosage forms of drugs (like tablets, capsules, injections) prepared from APIs and excipients.
• Nutraceuticals: Food products that provide health and medical benefits, including dietary supplements.
• EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization): A measure of a company's operating performance, indicating profitability before accounting for financing, taxes, and non-cash expenses.
• PE ratio (Price-to-Earnings ratio): A valuation metric that compares a company's current share price to its per-share earnings. It helps assess if a stock is overvalued or undervalued.
• CAGR (Compound Annual Growth Rate): The average annual growth rate of an investment over a specified period, assuming profits are reinvested.
• Share-swap deal: A corporate transaction where one company acquires another by exchanging its own stock for the target company's stock, rather than using cash.
• Omnichannel e-commerce: A retail strategy that integrates different sales channels (online, physical stores, mobile) to create a seamless customer experience.